Skip to main content

BlackRock, Inc.

Position in NBIX — Neurocrine Biosciences Inc

CIK 2012383 New York, NY

Position in NBIX

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$2,310,954,234
+$547,534,380 QoQ
Shares Held
13,711,607
+2.4% QoQ
Ownership
13.5%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1
of 768 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $21,635,633,053 across 65 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (10.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
13,711,607 $2,310,954,234

All Filings in NBIX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,310,954,234 13,711,607
2026-03-31 $1,763,419,854 13,385,607
2025-12-31 $1,819,763,561 12,830,597
2025-09-30 $1,783,700,555 12,706,230
2025-06-30 $1,628,284,399 12,954,765
2025-03-31 $1,623,872,772 14,682,394
2024-12-31 $2,017,841,547 14,782,722
2024-09-30 $1,642,581,841 14,256,048